A First-in-human Study of S230815 in Pediatric Participants With KCNT1-related Developmental and Epileptic Encephalopathy

NCT07227857 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Epileptic Encephalopathy

Interventions

DRUG: S230815- Starting dose A
DRUG: S230815- Dose B
DRUG: S230815- Dose C
DRUG: S230815- Dose D

Sponsor

Institut de Recherches Internationales Servier